培美曲塞、多西他赛联合顺铂一线治疗晚期肺腺癌的疗效观察(3)
 |
| 第1页 |
参见附件(2598KB，3页)。
[6] Dickgreber NJ, Fink TH, Latz JE, et al. Phase I and pharm acok inetic study of Pemetrexed plus cisp lat in in chemotherapy patients with locally advanced or metastatic m alignant pleuralm esothelioma or non-sm all cell lung cancer [J]. Clinic Cancer Res,2009,15(1):382-389.
[7] Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase Ⅲ trial of Pemetrexed versus Docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy [J]. J Clin Oncol,2004,22(9):1589.
[8] Scagliotti GV, Park K, Patil S, et al. Survival without toxicity for Cisplatin plus Pemetrexed versus Cisplatin plus gemcitabine in chemonaive patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study [J]. Eur J Cancer,2009,45(13):2298-2303.
[9] 母连军.培美曲塞获准作为非小细胞肺癌的一线治疗药[J].国外医药:抗生素分册,2008,29(6):285-286.
[10] Scagliotti GV, Parikh P, Von PJ, et al. Phase Ⅲ study comparing Cisplatin plus gemcitabine with Cisplatin plus Pemetrexed inchem otherapy naive patients with advanced stage non-small cell lung cancer [J]. J Clin Oncol,2008,26(21):3543-3551.
[11] Scagliotti G, Hanna N, Fossella F, et al. The differential efficacy of Pemetrexed according to NSCLC histology: a review of two phase Ⅲ studies [J]. Oncologist,2009,14(3):253-263.
[12] Syrigos KN, Vansteenkiste J, Parikh P, et al. Prognostic and predictive factors in a randomized phase Ⅲ trial comparing cisplatin-pemtrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer [J]. Ann Oncol,2010,21(3):556-561.
[13] Ciuleanu TE, Brodowicz T, Belani CP, et al. Maintenance Pemetrexed plus best supportive care( BSC) versu splacebo plus BSC: a phase Ⅲ study [J]. J Clin Oncol,2008,26(15 Supp l):8011.
[14] Peng G, Zinner RG, Wang Y, et al. Comparison of patient outcomes stratified by histology among Pemetrexed (P)-treated patients (pts) with stage Ⅲ B/Ⅳ non-small cell lung cancer(NSCLC) in two phase Ⅰ trials [J]. J Clin Oncol,2008,26(15 Supp l):809.
(收稿日期：2011-07-27)
您现在查看是摘要介绍页，详见PDF附件(2598KB，3页)。